399 related articles for article (PubMed ID: 25552581)
21. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.
Akerlund T; Svenungsson B; Lagergren A; Burman LG
J Clin Microbiol; 2006 Feb; 44(2):353-8. PubMed ID: 16455883
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.
Chung CH; Wu CJ; Lee HC; Yan JJ; Chang CM; Lee NY; Chen PL; Lee CC; Hung YP; Ko WC
J Microbiol Immunol Infect; 2010 Apr; 43(2):119-25. PubMed ID: 20457428
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
24. Epithelium-specific MyD88 signaling, but not DCs or macrophages, control acute intestinal infection with Clostridium difficile.
Mamareli P; Kruse F; Friedrich C; Smit N; Strowig T; Sparwasser T; Lochner M
Eur J Immunol; 2019 May; 49(5):747-757. PubMed ID: 30802297
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile infection.
Kelly CP; LaMont JT
Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
[TBL] [Abstract][Full Text] [Related]
26. The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice.
McDermott AJ; Higdon KE; Muraglia R; Erb-Downward JR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
Immunology; 2015 Apr; 144(4):704-16. PubMed ID: 25399934
[TBL] [Abstract][Full Text] [Related]
27. Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection.
Galdys AL; Curry SR; Harrison LH
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):967-80. PubMed ID: 24848084
[TBL] [Abstract][Full Text] [Related]
28. [Clostridium difficile infection in children--experience of clinical centre in Bydgoszcz].
Duleba K; Smukalska E; Pawłowska M
Przegl Epidemiol; 2012; 66(1):67-71. PubMed ID: 22708301
[TBL] [Abstract][Full Text] [Related]
29. The molecular basis of Clostridium difficile disease and host response.
El Feghaly RE; Bangar H; Haslam DB
Curr Opin Gastroenterol; 2015 Jan; 31(1):24-9. PubMed ID: 25394235
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.
Richardson C; Kim P; Lee C; Bersenas A; Weese JS
Anaerobe; 2015 Jun; 33():105-8. PubMed ID: 25769665
[TBL] [Abstract][Full Text] [Related]
32. Management of candidemia in patients with Clostridium difficile infection.
Falcone M; Venditti M; Sanguinetti M; Posteraro B
Expert Rev Anti Infect Ther; 2016 Jul; 14(7):679-85. PubMed ID: 27254270
[TBL] [Abstract][Full Text] [Related]
33. Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection.
Kim J; Kim H; Oh HJ; Kim HS; Hwang YJ; Yong D; Jeong SH; Lee K
Ann Lab Med; 2017 Jan; 37(1):53-57. PubMed ID: 27834066
[TBL] [Abstract][Full Text] [Related]
34. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
[TBL] [Abstract][Full Text] [Related]
35. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
36. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
37. Tigecycline for the treatment of severe Clostridium difficile infection.
Larson KC; Belliveau PP; Spooner LM
Ann Pharmacother; 2011 Jul; 45(7-8):1005-10. PubMed ID: 21730279
[TBL] [Abstract][Full Text] [Related]
38. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
[TBL] [Abstract][Full Text] [Related]
39. Clinical recognition and diagnosis of Clostridium difficile infection.
Bartlett JG; Gerding DN
Clin Infect Dis; 2008 Jan; 46 Suppl 1():S12-8. PubMed ID: 18177217
[TBL] [Abstract][Full Text] [Related]
40. C. difficile infection (CDI) in a long-term acute care facility (LTAC).
Goldstein EJ; Polonsky J; Touzani M; Citron DM
Anaerobe; 2009 Dec; 15(6):241-3. PubMed ID: 19683064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
